News
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced new data from its preclinical study of ZL-1503, the Company’s promising IL-13/IL-31R bispecific antibody, demonstrating its ability to ...
The BBC content job to replace Charlotte Moore is heating up with Zai Bennett dropping out and Tom McDonald and David ...
A live webcast of the fireside chat will be available on the Investor Relations page of Zai Lab’s website at ir.zailaboratory.com/webcasts-presentations and ...
Zai Lab Limited (NASDAQ:ZLAB) said on Monday that it received U.S. FDA fast track designation for its antibody-drug conjugate, ZL-1310, for the treatment of extensive-stage small cell lung cancer.
Full Year Revenue Guidance: Reaffirmed at $560 million to $590 million. Zai Lab Ltd (NASDAQ:ZLAB) reaffirmed its full-year revenue guidance of $560 million to $590 million, anticipating ...
For the quarter ended March 2025, Zai Lab Limited Unsponsored ADR (ZLAB) reported revenue of $106.49 million, up 22.2% over the same period last year. EPS came in at -$0.45, compared to -$0.55 in ...
May 08, 2025--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced financial results for the first quarter of 2025, along with recent product highlights and corporate updates.
Zai Lab Limited Unsponsored ADR (ZLAB) shares soared 21.5% in the last trading session to close at $29.54. The move was backed by solid volume with far more shares changing hands than in a normal ...
Zai Lab Limited is an innovative Pharma partnering with US and European Pharmas to secure approvals for, and market their drugs in China. ZLAB stock has surged over 105% in the past year ...
Zai Lab (ZLAB) “announced that China’s National Medical Products Administration has accepted the Biologics License Application for TIVDAK, tisotumab vedotin-tftv, for the treatment of patients ...
Scotiabank initiated coverage of Zai Lab (ZLAB) with an Outperform rating and $55 price target The firm says that although geopolitical risk has capped the stock’s upside for years, Zai Lab is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results